{"title":"FP02 Beta Training for Drug-Resistant Depression—A New Protocol That Usually Reduces Depression and Keeps It Reduced","authors":"Jonathan E. Walker, R. Lawson","doi":"10.1080/10874208.2013.785784","DOIUrl":null,"url":null,"abstract":"One hundred eighty-three patients with drug resistant depression were trained with 6 sessions of neurofeedback to reduce 2–7 Hz and increase 15–18 Hz at FP02 (the right fronto-polar orbital location). Remission or significant improvement (≥50%) occurred in 84% of subjects, as judged by the Rush Quick Self-Rated Depression Inventory. An additional 9% of patients experienced partial improvement. Improvement was maintained for 1 year or longer in all but 3 patients (1% of the entire group). These results indicate good efficacy in reducing drug-resistant depression and maintenance of the reductions in the majority of patients.","PeriodicalId":88271,"journal":{"name":"Journal of neurotherapy","volume":"17 1","pages":"198-200"},"PeriodicalIF":0.0000,"publicationDate":"2013-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/10874208.2013.785784","citationCount":"16","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neurotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/10874208.2013.785784","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 16
Abstract
One hundred eighty-three patients with drug resistant depression were trained with 6 sessions of neurofeedback to reduce 2–7 Hz and increase 15–18 Hz at FP02 (the right fronto-polar orbital location). Remission or significant improvement (≥50%) occurred in 84% of subjects, as judged by the Rush Quick Self-Rated Depression Inventory. An additional 9% of patients experienced partial improvement. Improvement was maintained for 1 year or longer in all but 3 patients (1% of the entire group). These results indicate good efficacy in reducing drug-resistant depression and maintenance of the reductions in the majority of patients.